TSX News -
VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme
CAMBRIDGE, MASSACHUSETTS–(Marketwired – Aug. 15, 2017) – VBI Vaccines Inc. (NASDAQ:VBIV) (TSX:VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation [...]